These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25136032)

  • 1. Re: Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Cristóbal I; Rincón R; Manso R; Rojo F; García-Foncillas J
    J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25136032
    [No Abstract]   [Full Text] [Related]  

  • 2. KRAS and cancer stem cells in APC-mutant colorectal cancer.
    Fearon ER; Wicha MS
    J Natl Cancer Inst; 2014 Feb; 106(2):djt444. PubMed ID: 24491303
    [No Abstract]   [Full Text] [Related]  

  • 3. Response.
    Moon BS; Cho YH; Jeong WJ; Choi KY
    J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25136033
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
    J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/beta-catenin signaling in cancer stemness and malignant behavior.
    Fodde R; Brabletz T
    Curr Opin Cell Biol; 2007 Apr; 19(2):150-8. PubMed ID: 17306971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K-ras and Wnt signaling synergize to accelerate prostate tumorigenesis in the mouse.
    Pearson HB; Phesse TJ; Clarke AR
    Cancer Res; 2009 Jan; 69(1):94-101. PubMed ID: 19117991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Wnt signaling in colon cancer stem cells.
    de Sousa EM; Vermeulen L; Richel D; Medema JP
    Clin Cancer Res; 2011 Feb; 17(4):647-53. PubMed ID: 21159886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA binding protein RBM3 increases β-catenin signaling to increase stem cell characteristics in colorectal cancer cells.
    Venugopal A; Subramaniam D; Balmaceda J; Roy B; Dixon DA; Umar S; Weir SJ; Anant S
    Mol Carcinog; 2016 Nov; 55(11):1503-1516. PubMed ID: 26331352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt and Kras signaling-dark siblings in lung cancer.
    Pacheco-Pinedo EC; Morrisey EE
    Oncotarget; 2011 Jul; 2(7):569-74. PubMed ID: 21753228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
    Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
    Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stem cell theory of colorectal cancer and its connection with molecular-biological data].
    Hagymási K; Molnár B; Sipos F; Galamb O; Tulassay Z
    Orv Hetil; 2007 Apr; 148(17):779-85. PubMed ID: 17452307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment.
    Kim JY; Lee HY; Park KK; Choi YK; Nam JS; Hong IS
    Oncotarget; 2016 Apr; 7(15):20395-409. PubMed ID: 26967248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCL9/9L-β-catenin Signaling is Associated With Poor Outcome in Colorectal Cancer.
    Moor AE; Anderle P; Cantù C; Rodriguez P; Wiedemann N; Baruthio F; Deka J; André S; Valenta T; Moor MB; Győrffy B; Barras D; Delorenzi M; Basler K; Aguet M
    EBioMedicine; 2015 Dec; 2(12):1932-43. PubMed ID: 26844272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras stabilization through aberrant activation of Wnt/β-catenin signaling promotes intestinal tumorigenesis.
    Jeong WJ; Yoon J; Park JC; Lee SH; Lee SH; Kaduwal S; Kim H; Yoon JB; Choi KY
    Sci Signal; 2012 Apr; 5(219):ra30. PubMed ID: 22494971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential WNT activity in colorectal cancer confers limited tumorigenic potential and is regulated by MAPK signaling.
    Horst D; Chen J; Morikawa T; Ogino S; Kirchner T; Shivdasani RA
    Cancer Res; 2012 Mar; 72(6):1547-56. PubMed ID: 22318865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/β-catenin and MAPK signaling: allies and enemies in different battlefields.
    Guardavaccaro D; Clevers H
    Sci Signal; 2012 Apr; 5(219):pe15. PubMed ID: 22494969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt signalling pathway in the serrated neoplastic pathway of the colorectum: possible roles and epigenetic regulatory mechanisms.
    Fu X; Li L; Peng Y
    J Clin Pathol; 2012 Aug; 65(8):675-9. PubMed ID: 22412046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic beta-catenin signaling networks in colorectal cancer.
    Fuchs SY; Ougolkov AV; Spiegelman VS; Minamoto T
    Cell Cycle; 2005 Nov; 4(11):1522-39. PubMed ID: 16258275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arl4c is a key regulator of tubulogenesis and tumourigenesis as a target gene of Wnt-β-catenin and growth factor-Ras signalling.
    Matsumoto S; Fujii S; Kikuchi A
    J Biochem; 2017 Jan; 161(1):27-35. PubMed ID: 28053143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt signaling in cancer.
    Zhan T; Rindtorff N; Boutros M
    Oncogene; 2017 Mar; 36(11):1461-1473. PubMed ID: 27617575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.